Get started
Author

Marjohn Armoon

Recent Trends in Real-World Frontline Treatment Patterns and Outcomes for Patients with Multiple Myeloma in the United States
2025 · Joshua Richter, Santosh Gautam, et al. · Clinical Lymphoma Myeloma & Leukemia · 2
Real World Evidence on Patient Reported Outcomes Among Newly Diagnosed Multiple Myeloma Patients Treated with Daratumumab-Based Regimens in Frontline (1L)
2024 · Smith Giri, Liton Francisco, et al. · Blood · 1
PDF
Real-World Characteristics and Treatment Patterns of Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma Treated with Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (DVRd) As Front-Line Treatment: Results from a Multicenter Chart Review Study
2024 · Carlyn Rose Tan, Lucio Gordan, et al. · Blood · 1
PDF
Characteristics, Treatment Patterns, and Outcomes of Patients with Multiple Myeloma Retreated with Daratumumab in Real-World Clinical Practice in the USA
2024 · Sikander Ailawadhi, Sarah M. Larson, et al. · Blood · 1
PDF
MAIA frailty subgroup analysis: long-term follow-up with daratumumab plus lenalidomide/dexamethasone in transplant-ineligible newly diagnosed myeloma
2026 · Thierry Facon, Gordon Cook, et al. · Leukemia
PDF
Effectiveness of daratumumab plus bortezomib, lenalidomide, and dexamethasone (DVRd) versus VRd for transplant-eligible newly diagnosed multiple myeloma
2026 · Carlyn Rose Tan, Lucio Gordan, et al. · Figshare
Effectiveness of daratumumab plus bortezomib, lenalidomide, and dexamethasone (DVRd) versus VRd for transplant-eligible newly diagnosed multiple myeloma
2026 · Carlyn Rose Tan, Lucio Gordan, et al. · Future Oncology
PDF
Effectiveness of Daratumumab plus Bortezomib, Lenalidomide, and Dexamethasone (DVRd) Versus VRd as Frontline Treatment for Transplant-Eligible Newly Diagnosed Multiple Myeloma: A Chart Review Study
2025 · Carlyn Rose Tan, Lucio Gordan, et al. · Clinical Lymphoma Myeloma & Leukemia
Works count: 8
Citation count: 5
H-index: 1
I10-index:
Year
Topic
Type